Dosing of Extracorporeal Cytokine Removal In Septic Shock (DECRISS): protocol of a prospective, randomised, adaptive, multicentre clinical trial

INTRODUCTION: Sepsis and septic shock have mortality rates between 20% and 50%. In sepsis, the immune response becomes dysregulated, which leads to an imbalance between proinflammatory and anti-inflammatory mediators. When standard therapeutic measures fail to improve patients’ condition, additional...

Descripción completa

Detalles Bibliográficos
Autores principales: Kanjo, Anna, Molnar, Zsolt, Zádori, Noémi, Gede, Noémi, Erőss, Bálint, Szakó, Lajos, Kiss, Tamás, Márton, Zsolt, Malbrain, Manu L N G, Szuldrzynski, Konstanty, Szrama, Jakub, Kusza, Krzysztof, Kogelmann, Klaus, Hegyi, Péter
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2021
Materias:
Intensive Care
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8395301/
https://www.ncbi.nlm.nih.gov/pubmed/34446497
http://dx.doi.org/10.1136/bmjopen-2021-050464

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8395301/
https://www.ncbi.nlm.nih.gov/pubmed/34446497
http://dx.doi.org/10.1136/bmjopen-2021-050464

Ejemplares similares